Core Points - The stock price of Reap Bio (300119) closed at 21.36 yuan on July 30, 2025, down by 0.23% with a turnover rate of 2.46% and a trading volume of 82,400 hands, amounting to 176 million yuan in transaction value [1] - The net outflow of main funds today was 10.54 million yuan, accounting for 5.98% of the transaction value, with large orders showing a net outflow of 13.68 million yuan, while small orders had a net inflow of 20.60 million yuan [1] - For the first quarter of 2025, the company reported total operating revenue of 822 million yuan, a year-on-year increase of 20.00%, and a net profit attributable to shareholders of 116 million yuan, up by 28.45% [1] Financial Metrics - The company's non-recurring net profit was 93.46 million yuan, reflecting a year-on-year growth of 19.65% [1] - The current ratio stands at 1.742, the quick ratio at 1.503, and the debt-to-asset ratio is 36.95% [1] Company Overview - Reap Bio Co., Ltd. was established in 2001 and is located in Tianjin, primarily engaged in technology promotion and application services [2] - The company has a registered capital of 4.65 billion yuan and a paid-in capital of 50.5 million yuan, with Li Shoujun as the legal representative [1][2] - The company has made investments in 40 enterprises, participated in 83 bidding projects, and holds 104 trademark registrations and 488 patents, along with 99 administrative licenses [2]
瑞普生物(300119)7月30日主力资金净流出1053.72万元